Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesRenal Toxicity following Zoledronic Acid Reversed with Ibandronate in a Prostate Cancer Patient with Bone Metastases
Urologia Internationalis, 06/30/08
Joensuu TK - Bisphosphonates are a standard treatment for metastatic bone disease, although agents vary in their potential for renal toxicity. This case report describes the reversal of zoledronic acid-induced renal toxicity by switching treatment to ibandronate in a patient with hormone-refractory prostate cancer and bone metastases.
Related Articles
Phenytoin-facilitated hypoglycaemia in ESRF
British Journal of Renal Medicine, 10/26/09
Relevance Score: 67%
Interindividual variability of drug transporters: Impact on opioid treatment in chronic renal failure
European Journal of Pain, 11/12/09
Relevance Score: 66%
Cardiovascular and renal toxicity during angiogenesis inhibition: clinical and mechanistic aspects
Journal of Hypertension, 11/20/09
Relevance Score: 65%
Polymyxin B and colistimethate are comparable as to efficacy and renal toxicity
Diagnostic Microbiology and Infectious Disease, 11/17/09
Relevance Score: 65%
Low toxicity regimens in renal transplantation: a country subset analysis of the Symphony study
Transplant International, 11/06/09
Relevance Score: 65%
Today in Acid-Base...keeping you current
Receive free subspecialty "5-minute updates" via email
Bone Disease in Medullary Sponge Kidney and Effect of Potassium Citrate Treatment
Clinical Journal of the American Society of Nephrology, 12/14/09
Acid-base regulation of angiotensin receptors in the kidney
Current Opinion in Nephrology and Hypertension, 12/11/09
Activation of p53 Promotes Renal Injury in Acute Aristolochic Acid Nephropathy
Journal of the American Society of Nephrology, 11/23/09
Article Search
Sponsor